Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant AXL (Tilvestamab Biosimilar) antibody

This Human Monoclonal antibody specifically detects AXL (Tilvestamab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.
Catalog No. ABIN7675645
-15% Promotion 2026
$294.23
$346.15
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 11 Business Days

Quick Overview for Recombinant AXL (Tilvestamab Biosimilar) antibody (ABIN7675645)

Target

AXL (Tilvestamab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
  • 1
Human

Clonality

  • 3
  • 1
Monoclonal

Conjugate

  • 3
  • 1
This AXL (Tilvestamab Biosimilar) antibody is un-conjugated

Application

Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-AXL / UFO Reference Antibody (tilvestamab)

    Sequence

    EVQLVESGGG LVQPGGSLRL SCAASGYSFT DFYINWVRQA PGKGLEWVAR IFPGGDNTYY NEKFKGRFTL SADTSKSTAY LQMNSLRAED TAVYYCARRG LYYAMDYWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPGK,DIQMTQSPSS LSASVGDRVT ITCRSSQSLV HSNGIPYLHW YQQKPGKAPK LLIYRVSNRF SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCSQGTHVP PTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

    Characteristics

    Anti-AXL / UFO Reference Antibody (tilvestamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.16 kDa.

    Purity

    >95 %

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: AXL inhibitors

    Conditions: Acute myeloid leukemia

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    AXL (Tilvestamab Biosimilar)

    Target Type

    Biosimilar

    Background

    Synonyms: UFO, ARK, TYRO7, Anexelekto, AZF

    Molecular Weight

    146.16 kDa

    UniProt

    P30530
You are here:
Chat with us!